首页 | 本学科首页   官方微博 | 高级检索  
     


Rituximab,lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B-cell lymphoma,leg type
Authors:Cosimo Di Raimondo  Farah R. Abdulla  Jasmine Zain  Christiane Querfeld  Steven T. Rosen
Affiliation:1. Division of Dermatology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA;2. Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA, USA;3. Division of Dermatology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA, USA

Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA

Abstract:
Keywords:drug antibodies  drug resistance  haematological malignancies  immunotherapy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号